Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,384,548
+$539,532 QoQ
Shares Held
12,108
+10.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#906
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. AMGN ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
This page
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,384,548 | 12,108 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,845,016 | 10,928 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,406,315 | 10,407 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,787,289 | 9,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,608,100 | 9,341 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,825,446 | 9,069 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,241,504 | 8,600 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,712,041 | 8,417 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,478,040 | 7,931 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,240,157 | 7,879 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,214,297 | 7,688 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,928,890 | 7,177 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,601,652 | 7,214 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,747,127 | 7,227 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,862,642 | 7,092 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,616,794 | 7,173 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,727,430 | 7,100 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,676,538 | 6,933 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,510,673 | 6,715 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,402,426 | 6,595 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,494,675 | 6,132 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,406,771 | 5,654 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,236,279 | 5,377 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,469,807 | 5,783 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,365,629 | 5,790 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $907,014 | 4,474 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||